Search results
11 gru 2020 · COMIRNATY ® (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech. It is approved as a 2-dose series for prevention of COVID-19 in individuals 16 years of age and older; It is also authorized under Emergency Use Authorization (EUA) to be administered for emergency use to:
- View PDF
The Pfizer-BioNTech COVID-19 Vaccine has received EUA from...
- Vaccines Manufacturing B-roll Video
This information—including product information—is intended...
- View PDF
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials , logistics, and manufacturing.
22 sie 2024 · Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single)...
Guidance below summarizes basic storage, preparation, scheduling, administration, and dosage for all 2024–25 Pfizer-BioNTech COVID-19 vaccine products.
11 wrz 2023 · The Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) is authorized for all doses administered to individuals 6 months through 11 years of age to prevent COVID-19. The Pfizer-BioNTech...
22 sie 2024 · Under the authorized dosing schedule, these individuals receive the Pfizer-BioNTech COVID−19 Vaccine before they turn 12 years old, and complete the vaccination series with COMIRNATY on or...
25 cze 2022 · Vaccines. Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron. Saturday, June 25, 2022 - 10:00am. View pdf copy Copy to clipboard Open in tab.
